Oral labetalol in the management of the sympathetic overactivity of severe tetanus.
D000284:Administration, Oral; D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D004983:Ethanolamines / Q000008:administration & dosage*; D006801:Humans; D007741:Labetalol / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D013742:Tetanus / Q000188:drug therapy*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D004983:Ethanolamines; D007741:Labetalol